首页> 外文期刊>Asia-Pacific Biotech News >Renhuang Pharmaceuticals Received Major Order from Anhui Huayuan Pharmaceutical
【24h】

Renhuang Pharmaceuticals Received Major Order from Anhui Huayuan Pharmaceutical

机译:仁煌药业收到安徽华元药业的重大订单

获取原文
获取原文并翻译 | 示例
       

摘要

Renhuang Pharmaceuticals Inc, a leading provider of natural health care products in the People's Republic of China (PRC), announced a major RMB 19 million (US 2.4 million dollar) order from Anhui Huayuan Pharmaceutical Co Ltd, which is one of the oldest and best known pharmaceutical companies in China. Renhuang Pharmaceuticals received the RMB 19 million order for 100,000,000 million doses (12 grams per dose) of Indigowoad Root, or "ban Ian gen", at the medical products purchasing conference in Taihe Town, Fuyang City in the Anhui Province. The conference is ranked as one of the biggest in the industry in China.
机译:中国领先的天然保健产品供应商仁煌药业有限公司宣布,获得安徽华源制药有限公司的一笔人民币1900万元(240万美元)的巨额订单,这是历史最悠久,也是最好的企业之一在中国知名的制药公司。在安徽省阜阳市太和镇举行的医疗产品采购大会上,仁煌药业有限公司获得了1900万元的订单,订购了1000亿个剂量的Indigowoad Root,即“ ban Ian gen”。该会议被评为中国业内规模最大的会议之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号